Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RENTON HOLLINGS −$249K Director sold 31% of stake

Reading 67 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-20 Suria Hamza President, CEO Sale −19,208 $35.75 $687K 74,122
2021-12-20 Suria Hamza President, CEO Sale −5,522 $36.40 $201K 68,600
2021-12-20 Suria Hamza President, CEO Exercise or conversion · Employee Stock Option (Right to Buy) −36,645 0
2021-11-26 Faga Daniel Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2021-11-26 Faga Daniel Director Grant or award · Stock Option (Right to Buy) +2,321 2,321
2021-11-15 Lizzul Paul F. Chief Medical Officer Grant or award +964 $22.03 $21K 964
2021-11-15 Suria Hamza President, CEO Grant or award +964 $22.03 $21K 68,600
2021-11-15 LOUMEAU ERIC J COO, General Counsel Grant or award +523 $22.03 $12K 523
2021-11-15 MULROY DENNIS Chief Financial Officer Grant or award +964 $22.03 $21K 964
2021-11-05 Suria Hamza President, CEO Exercise or conversion +14,302 $1.12 $16K 81,938
2021-11-05 Suria Hamza President, CEO Sale −14,302 $35.00 $501K 67,636
2021-11-05 Suria Hamza President, CEO Exercise or conversion · Employee Stock Option (Right to Buy) −14,302 0
2021-11-04 Suria Hamza President, CEO Exercise or conversion +6,059 $1.12 $7K 73,695
2021-11-04 Suria Hamza President, CEO Sale −6,059 $35.00 $212K 67,636
2021-11-04 Suria Hamza President, CEO Exercise or conversion · Employee Stock Option (Right to Buy) −6,059 14,302
2021-11-04 LOUMEAU ERIC J COO, General Counsel Exercise or conversion +2,500 $14.02 $35K 2,500
2021-11-04 LOUMEAU ERIC J COO, General Counsel Exercise or conversion +2,500 $20.16 $50K 5,000
2021-11-04 LOUMEAU ERIC J COO, General Counsel Sale −5,000 $35.00 $175K 0
2021-11-04 LOUMEAU ERIC J COO, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −2,500 85,500
2021-11-04 LOUMEAU ERIC J COO, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −2,500 7,500

Page 23 of 27 · 522 trades